Senior Hedge Fund Manager · QuantLogix Research · 07/04/2026 · 5 min read
$UTMD$HRMY$TGHL$AURA$IMNMRetail / Active InvestorsInstitutional / Hedge Funds / Family OfficesSignal Flipmedical-deviceshealthcareobstetrics-neonatal-care
← All QL Updates
Share:
Live signal check This article is a snapshot from 07/04/2026 — signals are live and move. Composite scores are rankings, not probabilities. Checking the current read… UTMD live signal →

UTMD Scores 96/100: What the Engine Sees at $72.78

UTMD ranks No. 1 on today's conviction list at 96/100, clearing a field of 562 Strong Buy signals. This is what a near-perfect 5-factor read looks like, what it typically precedes, and where the setup breaks down.

The Setup

U.S. equity markets are dark for the July 4 Independence Day holiday. UTMD is sitting at $72.78, unchanged on the session — 0% price movement. That flat tape is precisely what makes the signal interesting. With 562 Strong Buy flags against only 85 Strong Sell flags across the full QuantLogix universe — a bullish breadth skew of 6.6:1 — the 5-factor composite engine is running on pre-holiday factor inputs alone, not intraday momentum. UTMD leads the entire field with a 96/100 composite score. The number-two and number-three names — HRMY at 94/100 and TGHL at 93/100 — are also healthcare names, which is a secondary signal worth understanding before touching the primary one.

The Read

Start with what a 96 actually means architecturally. The QuantLogix 5-factor engine synthesizes momentum, value, quality, technical structure, and sentiment into a single 0–100 composite. A reading of 96 implies near-unanimous positive alignment across all five sub-scores simultaneously — not a spike in one factor while the others are neutral. Multi-factor composite models that combine momentum, value, quality, and technical signals have historically demonstrated superior out-of-sample performance relative to single-factor screens, particularly when factor signals are simultaneously aligned. That convergence is the signal; the individual factors are the anatomy lesson.

Where the Score Is Likely Built

Utah Medical Products designs, manufactures, and markets a broad range of disposable and reusable specialty medical devices used in obstetrics, gynecology, and neonatal intensive care. That business profile maps cleanly onto two of the five factors. The quality leg rewards gross margins — UTMD's are typically in the 55–60% range — and earnings stability. Utah Medical Products has maintained a consistent dividend program reflecting sustained free cash flow generation over multiple decades, which is exactly the kind of input that quality-factor models weight. The value leg benefits from the same free cash flow discipline; a company that pays dividends for multiple decades is compounding evidence of pricing power and cost structure resilience. Momentum and technical structure likely round out the read — the key diagnostic is whether those legs are confirming or merely not contradicting, which the sub-score breakdown on the signal detail page will clarify.

The Breadth Context

A 96/100 reading in a hostile signal environment — say, 200 Strong Buys against 400 Strong Sells — would warrant more skepticism. Today's 6.6:1 bullish-to-bearish ratio (562 Strong Buys, 85 Strong Sells) means the engine's macro-level model is also leaning constructive. UTMD's score is a leader within an already broadly constructive signal environment, which confirms macro-level model alignment rather than an isolated idiosyncratic read. The framework here is the Pod-Shop Model's core observation: a single high-conviction signal means more when the surrounding factor environment is aligned, not when it's fighting cross-currents.

Liquidity Is the First Risk Variable

Apply Position Sizing by Conviction × Liquidity before anything else. UTMD's average daily volume is typically under 30,000 shares per day. The mechanics are unforgiving: even a small position can face meaningful slippage, and the cost of exiting in a bad scenario is not fully visible at the time of entry. The signal is real; the liquidity constraint is also real. These two facts coexist and the sizing discipline must reflect both. This is a watchlist trigger and a research prompt, not an execution alert on the holiday session tape.

The Action

The Counter

Three counter-arguments deserve weight here, and the strongest is the liquidity-timing combination. A 96/100 score on a holiday-session flat tape is precisely the environment where spread costs and fill slippage can erase any edge the model identifies — the signal fires when you cannot cleanly act on it. That is not a reason to ignore it; it is a reason to treat it as a July 5 setup, not a July 4 execution. The second counter is factor crowding: healthcare's clean sweep of the top conviction slots (UTMD 96, HRMY 94, TGHL 93) may reflect broadly rewarded defensive and quality factors rather than name-specific alpha. When systematic funds read similar inputs simultaneously, the model's edge thins. The third counter is structural: UTMD operates in a mature niche with limited addressable market expansion. A quality signal accurately reflects balance sheet health while simultaneously failing to predict price appreciation if the market has already priced in the quality premium. The Anti-Index Mindset framework applies — the score tells you the factors are aligned; it does not tell you the market has not already processed the same information. That is the analytical work still required after the signal fires.

Primary Sources

Anonymized senior-practitioner discussion of frameworks for educational purposes — not personalized investment advice. QuantLogix is a research platform. Nothing in this article constitutes a recommendation to buy or sell any security. Past performance does not guarantee future results.